Compare Hubbell (HUBB) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hubbell vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Hubbell trades at $480 (market cap $25.12B), while Nuvation Bio Inc. Class A Common Stock trades at $5.22 (market cap $1.74B). The key difference: Hubbell is far larger — about 14.4× Nuvation Bio Inc. Class A Common Stock's market cap, and Hubbell pays a 1.19% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hubbell for 3 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| HUBB | NUVB | |
|---|---|---|
Market Cap | $25.12B | $1.74B |
Volume | 784,557 | 9,289,619 |
Sector | Industrials | Health |
52-Week High | $557.85 | $9.54 |
52-Week Low | $407.36 | $3.41 |
Typical Hold Time | 3 Days | 0 Days |
Enterprise Value | $30.28B | $1.33B |
Dividend Yield | 1.19% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hubbell
Hubbell manufactures electrical and utility products used in transmission, distribution, and electrical infrastructure. Its portfolio includes components and systems for utilities, data centers, industrial facilities, and buildings.
Read more on HUBB →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
